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OBJECTIVE—We investigated the regulation and involvement
of microRNAs (miRNAs) in fat cell development and obesity.
RESEARCH DESIGN AND METHODS—Using miRNA mi-
croarrays, we proﬁled the expression of 370 miRNAs during
adipogenesis of preadipocyte 3T3-L1 cells and adipocytes from
leptin deﬁcient ob/ob and diet-induced obese mice. Changes in
key miRNAs were validated by RT-PCR. We further assessed the
contribution of the chronic inﬂammatory environment in obese
adipose tissue to the dysregulated miRNA expression by tumor
necrosis factor (TNF)- treatment of adipocytes. We functionally
characterized two adipocyte-enriched miRNAs, miR-103 and
miR-143, by a gain-of-function approach.
RESULTS—Similar miRNAs were differentially regulated during
in vitro and in vivo adipogenesis. Importantly, miRNAs that were
induced during adipogenesis were downregulated in adipocytes
from both types of obese mice and vice versa. These changes are
likely associated with the chronic inﬂammatory environment,
since they were mimicked by TNF- treatment of differentiated
adipocytes. Ectopic expression of miR-103 or miR-143 in preadi-
pocytes accelerated adipogenesis, as measured both by the
upregulation of many adipogenesis markers and by an increase in
triglyceride accumulation at an early stage of adipogenesis.
CONCLUSIONS—Our results provide the ﬁrst experimental
evidence for miR-103 function in adipose biology. The remark-
able inverse regulatory pattern for many miRNAs during adipo-
genesis and obesity has important implications for understanding
adipose tissue dysfunction in obese mice and humans and the
link between chronic inﬂammation and obesity with insulin
resistance. Diabetes 58:1050–1057, 2009
A
dipose tissue is not only a storage depot of
triglycerides, but it is also an endocrine organ
and an important regulator of whole-body en-
ergy homeostasis (1–3). Abnormal fat accumu-
lation in obesity increases risk of life-threatening diseases
such as type 2 diabetes, atherosclerosis, and certain types
of cancer (4,5). Fundamental for the development of novel
therapeutics for obesity and its associated metabolic syn-
dromes is an understanding of the regulation of adipogen-
esis, which is tightly controlled by a combination of
multiple transcription factors and extracellular hormones
such as insulin (6–8).
Potential regulators of adipogenesis include microRNAs
(miRNAs), which encode an abundant class of 22 nucle-
otide evolutionarily conserved RNAs that control gene
expression at the posttranscriptional level by targeting
mRNAs for degradation or translational repression or both
(9–11). Computational and experimental analyses suggest
that miRNAs may regulate expression of 30% of human
and mouse genes (12). Furthermore, miRNAs are attrac-
tive candidates for regulating cell fate decisions and
complex diseases such as obesity because the simulta-
neous coordination of a large number of target genes,
potentially accomplished by a single miRNA, may be key
to deﬁning speciﬁc differentiated or pathogenic cell states.
Although miRNA expression proﬁles and functions
have been extensively investigated in the hematopoietic
system and neuronal and muscle tissues (13–15), little is
known about the role of miRNAs in metabolic tissues,
particularly adipose tissue (16). Of particular relevance,
miR-14 and miR-278 in the fat body of ﬂies regulate lipid
metabolism (17,18), miR-122 in mouse liver controls
triglyceride metabolism and cholesterol biosynthesis
(19,20), and experiments using antisense oligonucleo-
tides transfected into cultured human preadipocytes
suggested that miR-143 is involved in adipocyte differ-
entiation (21). Using Northern blot analyses, Kajimoto
et al. (22) proﬁled 100 miRNAs including three novel
miRNAs in 3T3-L1 cells before and after differentiation,
and Gu et al. (23) cloned 45 known and 2 novel miRNAs
from bovine adipose tissue. Moreover, as based on
computational analysis of miRNA target sites in their 3
untranslated region (UTR) sequences, 71% (282 out of
395) of expressed sequence tags with unique 3UTRs
differentially expressed during 3T3-L1 differentiation
are potentially regulated by miRNAs (24).
However, few adipocyte miRNAs have been analyzed, in
part because of the low sensitivity and coverage of cloning
and Northern blot analyses. Except for miR-143, none of
the candidate adipocyte–important miRNAs overlapped in
the studies of Esau et al. (21) and Kajimoto et al. (22).
Previous studies also used unfractionated primary adipose
tissue, which consists of a heterogeneous mixture of cell
types (23,25–28). And except for knocking down expres-
sion of miR-143, there have been no functional character-
izations of adipocyte miRNAs. Additionally, there has been
no systematic comparison of miRNA expression levels in
normal and obese states, despite the fact that many
adipose-important mRNAs are dysregulated in adipocytes
from obese animals and humans (25–28).
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Cell culture, differentiation, and chemical treatments. 3T3-L1 cells
(American Type Culture Collection) were cultured and differentiated as
described earlier (29). For tumor necrosis factor (TNF)- treatment, 1 nmol/l
human TNF- (PeproTech) was added to the growth medium on day 8 after
induction of differentiation and incubated for 24 h as described previously
(30).
Mouse studies. Male C57BL/6J and B6.V-Lep
ob/J (ob/ob) mice (Jackson
Laboratory) were maintained at the animal facility of the Whitehead Institute for
Biomedical Research. All animal experiments were performed with the approval
of the Massachusetts Institute of Technology Committee on Animal Care. For the
ob/ob model, all mice were provided with a normal diet. Epididymal fat pads were
harvested from mice at 16–17 weeks of age. For the diet-induced obesity (DIO)
model, we randomized 10 6-week-old male C57BL/6J littermates to either normal
diet or high-fat diet (55% fat, Teklad). After 3 months, epididymal fat pads were
harvested. Fat tissues from two to four mice of the same group were pooled
together as one biological sample for microarray or RT-PCR experiments.
Primary adipocytes were obtained after collagenase/dispase digestion, and en-
riched preadipocytes (CD11b
CD90
CD31
) were isolated by a negative selec-
tion on an autoMACS Separator according to the manufacturer’s instruction
(Miltenyi Biotec) (Supplementary Fig. S1, available in an online appendix at
http://diabetes.diabetesjournals/cgi/content/full/db08-1299/DC1).
miRNA microarray and data analysis. Total RNA including miRNA was
extracted using an miRNeasy Mini kit according to the manufacturer’s
protocol (Qiagen). Total RNA (6 g) was size-fractionated, and the small
RNAs (300 nt) isolated were 3-extended with a poly(A) tail using poly(A)
polymerase and labeled with Cy3 or Cy5. Hybridizations were performed on a
microﬂuidic biochip platform (LC sciences) as described previously (31).
Microarrays with miRNA content corresponding to miRbase v9.0 or v9.1 (nine
probes for each miRNA on one chip) were used for proﬁling during 3T3-L1
adipogenesis and for comparison between wild-type and ob/ob mice, whereas
microarrays with miRNA content corresponding to miRbase v10.1 (six probes
for each miRNAs on one chip) were used for comparison between control and
DIO mice. Data were analyzed by ﬁrst subtracting the background and then
normalizing the signals using a LOWESS ﬁlter. The ratio of the two sets of
detected signals (log2 transformed, balanced) and P values of the t test were
calculated for each probe; differentially regulated miRNAs were those with
50% repeating probes on one chip with P  0.01 (Student’s t test) between
the Cy3 and Cy5 signals. Overlapping differentially regulated miRNAs between
two biological replicates were considered as regulated miRNAs. Complete
miRNA microarray data and detailed protocols are deposited into Array-
Express (accession nos. E-MEXP-1789, E-MEXP-1930, and E-MEXP-1932).
miRNAs described in this article are referred to by their names in miRbase
v9.0.
Quantitative real-time RT-PCR assay. For miRNA RT-PCR, 10 ng RNA
was reverse-transcribed, and individual Taqman primers were used for
PCR according to the manufacturer’s instruction (Applied Biosystems).
snoRNA202 was used as the internal control. For mRNA RT-PCR, 1 g RNA
was reverse-transcribed with random primers by SuperScript II Reverse
Transcriptase (Invitrogen) and PCR ampliﬁed with gene-speciﬁc primers and
SYBR Green PCR master mix using ABI 7900HT according to the manufac-
turer’s protocol (Applied Biosystems). 18S was used as the internal control.
Data were analyzed by the relative quantiﬁcation (Ct) method. Primer
sequences are available upon request.
miRNA gene cloning and ectopic expression. Authentic miRNA stem-loop
and 220 nucleotides ﬂanking sequences on the 5 and 3 side of the mature
miR-103 or miR-143 was ampliﬁed from normal mouse genomic DNA (Clon-
tech) and cloned into the retroviral vector MDH.xdna as described previously
(32). Empty vector or expression plasmid with miRNA (8 g) was co-
transfected into 293T cells with retrovirus packaging vector pCL-Eco (4 g)
using FuGene 6 according to the manufacturer’s protocol (Roche). Virus
supernatant was collected and used to infect 3T3-L1 cells with the addition of
polybrene (Sigma) to a ﬁnal concentration of 4 g/ml. Infected cells were
sorted by ﬂuorescence-activated cell sorting to collect the top 30–40% highly
expressing green ﬂuorescent protein (GFP) cells.
Proliferation assay. 3T3-L1 cells expressing miRNA or empty vector alone
were seeded in 96-well plates (Corning) at a density of 10,000 cells per well.
After 3 days, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay was performed with an MTT Cell Proliferation Assay kit
according to the manufacturer’s protocol (American Type Culture Collection).
Triglyceride assay. On days 4 or 7 after differentiation, 3T3-L1 cells were
harvested in 300 l lysis buffer (50 mmol/l Tris-HCl, pH 7.4, 150 mmol/l NaCl,
1% Triton X-100) and sonicated to homogenize the cell suspension. Triglycer-
ide level was measured using a serum triglyceride determination kit according
to the manufacturer’s instructions (Sigma). Protein was measured by a DC
protein assay kit according to the manufacturer’s protocol (Bio-Rad).
Statistical analysis. Data are expressed as means 	 SE unless otherwise
indicated. Student’s t test (unpaired, two-tailed) was used to compare the two
groups, and the P value was calculated in Excel (Microsoft) or GraphPad
Prism 5 (GraphPad Software). Pearson’s correlation analysis and Fisher’s
exact test were performed in GraphPad Prism 5 (GraphPad Software). For
Pearson’s correlation analysis, miRNAs from the same genomic cluster (50
kb) were treated as one entity and their expression levels were averaged. P 
0.05 was considered as statistically signiﬁcant.
RESULTS
miRNA expression during in vitro adipogenesis of
3T3-L1 preadipocytes. We proﬁled the expression of
miRNAs during 3T3-L1 cell adipogenesis using miRNA mi-
croarrays detecting 373 mouse mature miRNAs (miRbase
v9.0). Data from two biological replicates were consistent
(data not shown). Most miRNAs fell along the diagonal
line in the intensity scatter plot, indicating that they were
not regulated during the 9 days of adipogenesis (Fig. 1A).
Based on criteria described in RESEARCH DESIGN AND METHODS,
28 miRNAs were expressed at signiﬁcantly different levels
between undifferentiated 3T3-L1 preadipocytes (day 0)
and differentiated 3T3-L1 adipocytes (day 9) (Fig. 1A, P 
0.01, Student’s t test). Expression proﬁles of miRNA
isolated during 3T3-L1 differentiation indicated that major
changes occurred as early as days 2–4 (data not shown).
Of the miRNAs differentially expressed, the eight miRNAs
signiﬁcantly upregulated during differentiation, namely
miR-422b, 148a, 107, 103, 30c, 30a-5p, 146b, and 143, and
the four downregulated miRNAs, namely miR-125b, 99b,
222, and 221, were selected for validation by quantitative
RT-PCR assays using samples derived from an indepen-
dent set of experiments. The results conﬁrmed our ﬁnd-
ings from the microarrays (Fig. 1B).
miRNA expression during primary fat cell development.
To further examine the expression proﬁles during in vivo
fat cell development, enriched epididymal adipocytes
were puriﬁed by ﬂoatation after collagenase/dispase
digestion and dissociation; enriched preadipocytes
(CD11b
CD90
CD31
) in the stromal vascular fraction
were depleted of ﬁbroblasts, endothelial cells, macro-
phages, and erythrocytes (supplementary Fig. S1). Differ-
entiation of these enriched preadipocytes showed
enhanced formation and accumulation of lipid droplets
compared with the total population of cells in the stromal
vascular fraction (data not shown). Expression levels of
the same 12 selected miRNAs shown in Fig. 1B were
measured by RT-PCR in RNAs from enriched preadipo-
cytes and mature primary adipocytes. As shown in Fig. 1C,
9 of 12 miRNAs exhibited a similar regulation pattern
compared with in vitro differentiation. Noteworthy is the
fact that miR-143 expression increases to a larger extent in
vivo compared with adipogenesis of 3T3-L1 cells; this is
one of the miRNAs we selected for overexpression in
3T3-L1 preadipocytes (Fig. 6).
Coexpression of intronic miRNAs with “host” genes.
Some of the differentially regulated miRNAs originated
from introns of known genes. For example, miR-422b is
located in the sense orientation in the ﬁrst intron of
peroxisome proliferator–activated receptor (PPAR)-
 co-
activator 1 (PPARGC1b). miR-107, miR-103-1, and miR-
103-2 reside in the sense orientation in intron 5 of three
Pantothenate kinase (PANK) gene family members:
PANK1, PANK3, and PANK2, respectively. All of these
intronic miRNAs were co-regulated with their respec-
tive host genes during 3T3-L1 adipogenesis (Fig. 1D).
miRNA expression in adipocytes from obese mice. To
identify candidate miRNAs associated with abnormal fat
H. XIE, B. LIM, AND H.F. LODISH
DIABETES, VOL. 58, MAY 2009 1051accumulation, the same miRNA microarrays were used to
compare miRNA levels in normal adipocytes with those of
obese mice. We ﬁrst used leptin-deﬁcient ob/ob mice; at 4
weeks of age, ob/ob mice are obese and exhibit hypergly-
cemia, glucose intolerance, and insulin resistance, pheno-
types that resemble the pathophysiology of human type 2
diabetes (33). A total of 71 miRNAs were expressed at
signiﬁcantly different levels (Fig. 2A, P  0.01, Student’s t
test). Twelve regulated miRNAs, including 9 downregu-
lated and 3 upregulated in ob/ob mice, were validated by
RT-PCR assays (Fig. 2B).
We also used DIO mice as a model of obesity. After being
fed with a 55% high-fat diet for 3 months (from weeks 6 to
18), DIO mice became signiﬁcantly heavier than normal mice
and had almost twice the mass of epididymal fat compared
with littermate controls (Fig. 3A and B, P  0.01, Student’s t FIG. 1. miRNA expression proﬁling during 3T3-L1 adipogenesis. A:
Intensity scatter plot showing comparison of miRNA proﬁles between
undifferentiated 3T3-L1 preadipocytes (day 0) and differentiated
3T3-L1 adipocytes (day 9). The 12 miRNAs that are the focus of our
detailed analyses are highlighted in red and indicated by a label. B:
Validation of miRNA array results for 12 regulated miRNAs by RT-PCR
assays. Expressions for all miRNAs are plotted as fold-change in log2
scale; positive indicates enriched in day 9 vs. day 0. , Array result
(n  2); f, RT-PCR result (n  4). Data are expressed as means  SE.
C: Comparison by RT-PCR of miRNA regulation during 3T3-L1 differ-
entiation and primary fat cell development. Expressions of all miRNAs
are normalized to internal control and plotted as fold-change in
log2 scale. f, day 9 vs. day 0, same data as Fig. 1B (n  4); , mature
adipocytes vs. enriched preadipocytes (n  4). Data are expressed as
mean  SE. D: Intronic miRNAs and their host genes are co-regulated
during adipogenesis. miR-422b is in the intron of PPARGC1b; miR-107
is in the intron of PANK1; the two copies of miR-103 are in the introns
of PANK2 and PANK3. miRNA expression levels are measured by
RT-PCR and normalized to internal control. Expression levels of
mRNAs are also determined by RT-PCR and normalized to internal
control. Expressions are shown as fold-change relative to the level at
day 0. , day 0; f, day 2; o, day 4. Data are expressed as mean  SE
(n  3).
FIG. 2. miRNA expression proﬁling in adipocytes from wild-type (WT)
and leptin-deﬁcient ob/ob mice. A: Intensity scatter plot showing
comparison of miRNA proﬁles in adipocytes from WT and ob/ob mice.
The 12 miRNAs that are the focus of our detailed analyses are
highlighted in red and indicated by a label. B: Validation of miRNA
array results for 12 regulated miRNAs by RT-PCR assays. Expression of
all miRNAs are normalized to internal control and plotted as fold-
change in a log2 scale. , Array result (n  2); f, RT-PCR result (n 
2). Data are expressed as mean  SE.
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ing 569 mouse miRNAs (miRbase v10.1) and 5 novel miRNAs
cloned from adipose tissue by Kajimoto et al. (22) and Gu et
al. (23) for this comparison, 35 miRNAs were expressed at
signiﬁcantly different levels (Fig. 3C, P  0.01, Student’s t
test). Notably, the recently discovered mirtron miR-1224
and one novel miRNA cloned from bovine adipose tissue
(Novel_miR#5: 5-GGGCCGUGCGCGGGGUCUGC-3)
were expressed above the mean of expression of all
miRNAs. Six miRNAs including four upregulated and two
downregulated in DIO mice were selected for validation
with RT-PCR assays; the results again agreed well with the
microarray data (data not shown).
To compare changes in miRNA expression between
these two models of obesity, we focused on a set of 78
miRNAs, whose expression levels were above the mean
expression of all miRNAs in at least one of the four samples
analyzed: enriched adipocytes from wild-type and ob/ob mice
(Fig. 2) and adipocytes from control and DIO mice (Fig. 3C).
As shown in Fig. 3D, there was a strong positive correlation
between changes in miRNA expression levels in the two
obesity models (r  0.51, P  0.0001, Pearson’s correlation).
This suggested that similar sets of miRNAs are up- or
downregulated in these two models of obesity, although the
extent of regulation was usually more striking in adipocytes
from ob/ob mice than DIO mice.
Inverse correlation of miRNA expression during ad-
ipogenesis and obesity. Importantly, we noticed that
miRNAs upregulated during adipogenesis tended to be
downregulated in the obese state, and vice versa. For
example, miR-422b, 148a, 107, 103, 30c, 30a-5p, and 143
were induced during adipogenesis but were downregu-
lated in obese adipocytes. Conversely, miR-222 and -221
were decreased during adipogenesis but were upregulated
in obese adipocytes (Figs. 1B and 2B).
To test our observation more rigorously and on a larger
scale, we focused on a set of 79 miRNAs, whose expres-
sion levels were above the mean expression of all miRNAs
in at least one of the four samples analyzed: undifferenti-
ated 3T3-L1 preadipocytes (day 0), differentiated 3T3-L1
adipocytes (day 9), and adipocytes from wild-type and
ob/ob mice. The regulation patterns of these 79 miRNAs
are shown as a scatter plot in Fig. 4A (r  0.51, P 
0.0001, Pearson’s correlation) and categorized in Fig. 4B.
Among the 41 miRNAs upregulated during differentiation,
31 miRNAs decreased during obesity. In contrast, among
the 38 miRNAs downregulated during differentiation, 26
miRNAs were elevated during obesity. The inverse corre-
lation between miRNAs implicated in adipogenesis and
obesity was statistically signiﬁcant (Fig. 4B, P  0.0001,
Fisher’s exact test).
miRNA regulation by TNF- in adipocytes from obese
mice. Chronic inﬂammation by macrophages is a principal
feature of obese adipose tissue (3,34–36); TNF- is a major
macrophage-produced cytokine involved in chronic in-
ﬂammation and is largely responsible for inducing insulin
resistance in obese adipose tissue (37). Previously, we
reported that in 3T3-L1 adipocytes, TNF- treatment sup-
pressed expression of many adipocyte-speciﬁc genes and
reactivated expression of preadipocyte genes, inducing
insulin resistance (30). Figure 5 shows, using quantitative
RT-PCR assays, that treatment of differentiated 3T3-L1
adipocytes for 24 h with TNF- reduced the expression of
the same miRNAs, including miR-103 and miR-143, which
were downregulated in adipose tissue from ob/ob mice.
Conversely, TNF- induced the expression of three
FIG. 3. miRNA expression proﬁling in adipocytes from control and DIO
mice. A: Weight of control and DIO mice (n  5). DIO mice were fed
with a 55% high-fat diet starting from week 6 to week 18. Controls were
fed with a normal diet. Data are expressed as means  SE. **P < 0.01.
B: Weight of epididymal fat pads from control and DIO mice (n  5) at
week 18. **P < 0.01. C: Intensity scatter plot showing comparison of
miRNA proﬁles in adipocytes from control and DIO mice. Mirtron
miR-1224, Novel_miR#5 (novel miRNA cloned from bovine adipose
tissue described in the text), and some miRNAs used in our detailed
analyses are highlighted in red and indicated by a label. D: Scatter plot
showing the positive correlation of miRNA regulation in two disease
models for obesity: ob/ob and DIO mice. A total of 78 miRNAs, whose
levels are above the mean expression of all miRNAs in at least one of
the four samples (enriched adipocytes from wild-type [WT], ob/ob,
control, and DIO mice), are shown. Fold-changes are based on array
results and plotted in a log2 scale. Some miRNAs used in our detailed
analyses are highlighted in red and indicated by a label. Pearson’s
correlation coefﬁcient: r  0.51, P < 0.0001.
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normally downregulated during adipogenesis and upregu-
lated during obesity. Thus, the changes in miRNA expres-
sion we observed in adipocytes from both ob/ob and DIO
mice likely were caused by the enhanced expression of
TNF- seen in obese adipose tissue.
miR-103 and miR-143 accelerate adipogenesis when
expressed ectopically. To determine whether the changes
in miRNA expression we observed might affect adipogen-
esis, we focused on two miRNAs, miR-103 and miR-143,
which were upregulated during adipogenesis and down-
regulated during obesity. Both miRNAs are highly con-
served and are abundant in adipocytes. The level of
mature miR-143 increased slightly during 3T3-L1 adipogen-
esis, but the rise is much more dramatic in vivo (Figs. 6A
and 1C). Expression of miR-103 was induced approxi-
mately ninefold during adipogenesis, with the increase
occurring mainly after day 2 (Fig. 6A).
To evaluate the effects of these miRNAs on preadipocyte
growth and differentiation, we used a retroviral vector to
stably express them in 3T3-L1 preadipocytes. GFP was used
as a reporter so that infected 3T3-L1 cells could be easily
selected by ﬂuorescence-activated cell sorting. We obtained
four independent batches of miRNA overexpressing cells.
GFP
 cells expressed three- to fourfold higher levels of
mature miRNA than control preadipocytes, which expressed
the empty vector alone (Fig. 6B). Thus, miR-103 and miR-143
were ectopically expressed at physiological levels.
Figure 6C shows that ectopic expression of miR-103 or
miR-143 has little effect on 3T3-L1 cell growth. Without
adipogenic stimuli, there were no evident morphological
changes in 3T3-L1 cells ectopically expressing these miR-
NAs (data not shown). However, ectopic expression of
miR-103 or miR-143 did accelerate the rate of 3T3-L1
differentiation, as measured by triglyceride accumulation
(Fig. 6D) and by the upregulation of many adipocyte-
important genes at early stages of adipogenesis (Fig. 6E).
Figure 6D shows that cells ectopically expressing either
miR-103 or miR-143 accumulated twice the normal level of
triglyceride at day 4 of differentiation but a normal level of
triglyceride at day 7.
The accelerated differentiation was accompanied by in-
creased expression of key transcription factors such as
PPAR
2, key cell cycle regulators such as G0/G1 switch 2
(G0s2), and molecules associated with lipid metabolism
(FABP4), glucose homeostasis (GLUT4), and endocrine func-
tions (adiponectin) of adipocytes. Quantitative RT-PCR
showed that ectopic expression of miR-103 or miR-143
caused little change in the low level of expression of these
genes before the onset of differentiation (day 0). Importantly,
ectopic expression of miR-103 or miR-143 did hasten the
expression of these pro-adipogenic factors at early stages of
adipogenesis (Fig. 6E and F). At day 2, for example, expres-
sion of PPAR
2 was doubled by ectopic expression of either
FIG. 4. Inverse correlation of miRNA expression during adipogenesis
and obesity. A: Scatter plot showing the inverse correlation of miRNA
regulation during adipogenesis and obesity. A total of 79 miRNAs,
whose levels are above the mean expression of all miRNAs in at least
one of the four samples (undifferentiated 3T3-L1 preadipocytes [day
0], differentiated 3T3-L1 adipocytes [day 9], and adipocytes from
wild-type [WT] and ob/ob mice) are shown. Fold-change is based on
array result and plotted in a log2 scale. The 12 miRNAs that are the
focus of our detailed analyses are highlighted in red and indicated by a
label. Pearson’s correlation coefﬁcient: r  0.51, P < 0.0001. B:
Fisher’s exact test for 79 miRNAs is shown in Fig. 3A. A total of 41
miRNAs were upregulated during differentiation (Diff_Up), among
which 31 miRNAs were downregulated during obesity (Ob_Down),
whereas 10 miRNAs were upregulated (Ob_Up). A total of 38 miRNAs
were downregulated during differentiation (Diff_Down), among which
26 miRNAs were upregulated during obesity (Ob_Up), whereas 12
miRNAs were downregulated (Ob_Down). P  0.0001 by Fisher’s exact
test.
FIG. 5. miRNAs differentially expressed in adipocytes from ob/ob mice
compared with wild-type (WT) mice are regulated similarly by TNF-
treatment of 3T3-L1 differentiated adipocytes for 24 h. miRNA levels
are measured by RT-PCR, normalized to internal control and plotted as
fold-change in log2 scale. x-axis, ob/ob vs. WT, same data as Fig. 2B;
y-axis, differentiated adipocyte after TNF- treatment for 24 h versus
untreated control (n  4). Pearson’s correlation coefﬁcient: r  0.90,
P < 0.0001.
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of FABP4 and adiponectin approximately ninefold and four-
fold, respectively (Fig. 6F). Gene expression proﬁling by
microarrays (data not shown) also suggested a signiﬁcant
enrichment of other proteins known to be important during
adipogenesis or in lipid metabolism pathways in day 2 cells,
in which miR-103 or miR-143 was ectopically expressed
compared with control cells at day 2. Notably, neither
miR-103 nor miR-143 modulated early adipogenic markers
such as LPL at day 0 (Fig. 6E and data not shown). Levels of
miR-103 and miR-143 are normally induced early in differen-
tiation, and they likely downregulate expression of unknown
mRNAs whose encoded protein(s) normally slow the pro-
cess of adipogenesis.
DISCUSSION
In this study, we have generated a comprehensive database of
the expression patterns of over 370 known mouse mature
miRNAs during normal fat cell development and, for the ﬁrst
time, in adipocytes from normal and obese mice. Similar
changes in miRNA expression occur during in vitro and in vivo
adipogenesis. Many of these differentially regulated miRNAs are
likely to be important in adipose biology, as we showed that
ectopic expression of two normally upregulated miRNAs, miR-
103 or miR-143, in preadipocytes accelerates the rate of fat cell
formation. Importantly, miRNAs that were induced during adi-
pogenesis were decreased in adipocytes from both types of
obese mice and vice versa. We suggest that these changes are
linked to the chronic local inﬂammation environment and
enhanced TNF- levels in obese adipose tissue, since similar
changes in the pattern of miRNA expression occurred after
TNF- treatment of differentiated adipocytes. Our work pro-
vides an important ﬁrst step toward construction of the entire
RNA regulatory network underlying fat cell development and
adipose dysfunction in obesity. An understanding of the role of
miRNAs in adipose biology may lead to novel RNA-based
therapies that complement current anti-obesity treatments.
Regulated expression of functionally important miRNAs.
Our genome-wide miRNA proﬁling study identiﬁed many differ-
entially regulated miRNAs, including miR-103 and miR-143.
miR-143 is likely to be important in adipocyte biology, since
transfection of antisense miR-143 oligonucleotides in cultured
human preadipocytes inhibits all ﬁve adipocyte differentiation
markers by at least 40% (21). Our experiments ectopically
expressing miR-143 resulted in the opposite effect, upregulation
of adipogenesis markers, thus conﬁrming its important role in
modulating adipogenesis.
Wang et al. (38) reported that the miR-17-92 cluster is upregu-
lated twofold only during the early clonal expansion stage of
adipogenesis and that these miRNAs accelerate adipocyte dif-
ferentiation by negatively regulating p130. Because we focused
only on miRNAs upregulated during adipose differentiation per
se, our microarray analyses did not identify the miR-17-92
FIG. 6. Ectopic expression of two adipocyte-induced miRNAs, miR-103
or miR-143, accelerates adipogenesis. A: miR-103 and miR-143 are
induced during 3T3-L1 adipogenesis. miRNA expression levels are
measured by RT-PCR, normalized to internal control and plotted
relative to their respective levels in preadipocyte (day 0). Data are
expressed as mean  SE (n  3). B: Expression level of miR-103 or
miR-143 in infected and sorted cells compared with vector control.
Data are expressed as mean  SE (n  3). C: Ectopic expression of
miR-103 or miR-143 has little effect on 3T3-L1 cell growth by MTT
assay. Data are expressed as mean  SE (n  6). D: Ectopic expression
of miR-103 or miR-143 increases triglyceride accumulation at day 4
(D4) but not day 7 (D7). Triglycerides are normalized to total protein
and plotted relative to the level of the control cells expressing vector
alone at D7. Data are expressed as mean  SE (n  6). **P < 0.01, *P <
0.05. E: Ectopic expression of miR-103 or miR-143 hastens expression
of adipogenic markers at an early stage (days 2 and 4) of adipogenesis.
mRNA levels are measured by RT-PCR, normalized to internal control
and plotted relative to their respective levels at day 2 (D2). Data are
expressed as mean only (n  3). PPARG2, peroxisome proliferator-
activated receptor  2; G0s2, G0/G1 switch 2; FABP4, fatty acid binding
protein 4; GLUT4, glucose transporter 4; LPL, lipoprotein lipase. F:
Ectopic expression of miR-103 or miR-143 hastens expression of
adipogenic markers at day 2 (D2). Data are expressed as mean  SE (n 
4). ***P < 0.001, **P < 0.01, *P < 0.05 by one-sample Student’s t test.
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changes during the clonal expansion phase in part because
there are no primary cell samples corresponding to this stage. In
addition, according to our microarray data, the miR-17-92 clus-
ter is not abundantly expressed in differentiated adipocytes.
Importantly, we also studied puriﬁed primary adipocytes,
which are more homogeneous than the unfractionated pri-
mary adipose tissue used in an earlier study (23); this enabled
us to identify adipocyte-enriched miRNAs. Comparing the 44
miRNAs most highly expressed in epididymal adipocytes
from normal mice with the 29 miRNAs most highly expressed
in chondrocytes and osteoblasts (39), expression of 18
miRNAs, including let-7, miR-23, miR-26, and miR-30, are
common to all three lineages. This suggests that they are
functionally important for differentiation of all three cell
types (adipocytes, chondrocytes, and osteoblasts) that are
formed from mesenchymal stem cells (40). In contrast,
miRNAs preferentially enriched in one particular mesenchy-
mal lineage may have roles in cell fate determination and
lineage differentiation of mesenchymal stem cells or be
required for the function of these differentiated cells. As an
example, miR-140 is enriched in osteoblasts and chondro-
cytes, and miR-140 was reported previously to be important
for bone development by downregulating histone deacety-
lase 4 (41).
Downstream effectors and targets for miR-103 and
miR-143. A computational study predicted that the
miRNA paralogs miR-103 and miR-107 affect multiple
mRNA targets in pathways that involve cellular acetyl-CoA
and lipid metabolism (42). Supplementary Tables S1 and
S2 suggest many potentially important mRNA targets for
miR-103 and miR-143, including several anti-adipogenic
factors such as ARNT, FZD1, and RUNX1T1/ETO/MTG8,
whose levels are normally downregulated during adipo-
genesis. These genes were selected based on meeting all of
the following criteria: 1) expressed in 3T3-L1 cells at day 0
or day 2, 2) a lower mRNA expression level in day 2 cells
in which miRNA is ectopically expressed compared with
control cells at day 2, and 3) predicted targets based on
TargetScan v4.2 (12,43).
Some targets not listed here may have decreased protein
levels but unchanged mRNA levels; some may be pre-
dicted by computational softwares other than Targetscan.
Importantly, miRNAs likely target many mRNAs (10,11),
and deﬁning one major target of either miRNA will be
difﬁcult and likely impossible. For example, many miR-143
targets shown in supplementary Table S2 are equally if not
more interesting than MAPK7/ERK5, which was previously
suggested as an miR-143 target (21). Validation of potential
targets by luciferase reporter assays and Western blots is
ongoing but beyond the scope of this article.
Functionally important adipocyte miRNAs are down-
regulated in obesity, likely because of macrophage
inﬁltration and TNF-. Most strikingly, several miRNAs,
including miR-103 and miR-143, exhibit inverse patterns of
regulation during adipogenesis compared with those dur-
ing obesity (Fig. 4A), indicating that obesity leads to a loss
of miRNAs that characterize fully differentiated and met-
abolically active adipocytes. Earlier studies reported that
many adipogenic genes whose expression increases dur-
ing adipogenesis, displayed markedly decreased expres-
sion in adipocytes from epididymal fat pads of ob/ob and
DIO mice (25–27).
In general, we observed a greater extent of miRNA
dysregulation in adipocytes from ob/ob compared with
DIO mice. In parallel, several groups reported a greater
change of altered mRNA expression in adipocytes from
ob/ob mice than DIO mice (25–27). This is likely because
ob/ob mice have increased adiposity compared with DIO
mice of the same age (data not shown). Alternatively, 3
months of a high-fat diet might not be long enough to
induce the same changes as seen in adipocytes from ob/ob
mice. Nevertheless, the positive correlation of miRNA
regulation we observed in these two different models of
obesity (Fig. 3D) suggests that the changes in the adipo-
cyte miRNA expression proﬁle in ob/ob mice cannot result
from leptin deﬁciency alone.
More likely these changes are associated with the
chronic inﬂammatory environment in obese adipose tis-
sue. Increased expression of inﬂammation-related genes
was found in isolated abdominal subcutaneous adipocytes
and cultured stromal vascular cells from obese Pima
Indians compared with nonobese control subjects (44,45).
We hypothesize that one or more miRNAs upregulated
upon TNF- treatment of adipocytes are involved in
destabilizing PPAR
 or CCAAT/enhancer-binding protein
 or another mRNA encoding an adipocyte-important
transcription factor.
Ruan et al. (30) reported that TNF- suppressed adipo-
cyte-speciﬁc genes and activated expression of preadipo-
cyte genes in 3T3-L1 cells. In parallel, we showed here
that, in 3T3-L1 adipocytes, TNF- repressed miRNAs that
are normally upregulated during adipogenesis. Thus, ele-
vated levels of TNF- in obese adipose tissue are likely the
cause of the changes in miRNA levels we observed in
obesity. Our results (Fig. 5) also suggested that obesity
had a much stronger impact on the expression of these
miRNAs than did exposure of 3T3-L1 cells to TNF-. These
differences are probably due to the relatively long half-life
of miRNAs and some delay in transcription in response to
TNF- treatment. Additionally, the chronic inﬂammatory
state of obese adipose tissue likely depends on other
inﬂammatory cytokines such as IL-6, leading to impaired
adipose tissue function.
miRNAs are highly connected nodes in regulatory
networks underlying adipogenesis and adipose dys-
function in obesity. Only a small fraction of known
miRNAs is signiﬁcantly regulated during adipogenesis
(Fig. 1A). However, each miRNA is thought to regulate, on
average, about 200 target genes and has widespread im-
pact on protein output (10,11). Multiple miRNAs can act
additively or synergistically at multiple target sites on a
single mRNA (46). The potential interaction networks
connecting miRNAs and mRNAs are enormous and can be
further expanded by feedback or feed-forward loops (47).
Whereas miR-103 and miR-143 have been suggested to be
important for adipogenesis, little is known about the
speciﬁc mRNA targets of these miRNAs. Their effects on
adipogenesis could be achieved by signiﬁcant downregu-
lation of one or two “primary” target mRNAs or by more
modest downregulation of perhaps hundreds of preadipo-
cyte-important mRNAs. Clearly, we need to identify bio-
logically relevant targets for these key miRNAs. In the
reconstructed regulatory network, each miRNA will likely
link to multiple target genes and serve as a controlling
point and potential target for therapeutic intervention.
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